Association of acylcarnitines with maternal cardiometabolic risk factors is defined by chain length: the S-PRESTO study.

Li ChenXue Ping GohAnne K BendtKaren Mei-Ling TanMelvin Khee-Shing LeowKok Hian TanJerry K Y ChanShiao-Yng ChanYap-Seng ChongPeter D GluckmanJohan G ErikssonMarkus R WenkSartaj Ahmad Mir

Published in: The Journal of clinical endocrinology and metabolism (2024)

This study provides the metabolic and physiological basis of maternal carnitine homeostasis, which can be used in assessment of maternal cardiometabolic health at preconception to improve pregnancy outcomes.

Keyphrases

pregnancy outcomes
risk factors
pregnant women
public health
physical activity
body mass index
weight gain